About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Understanding the Cause and Possible Treatment for a Rare Form of Sarcoma

by Dr. Trupti Shirole on November 25, 2016 at 8:22 AM
Font : A-A+

 Understanding the Cause and Possible Treatment for a Rare Form of Sarcoma

Inflammatory myofibroblastic tumor is a rare soft tissue cancer that does not respond to radiation or chemotherapy. Researchers at Mayo Clinic Center for Individualized Medicine have discovered a potential cause and a promising new treatment for inflammatory myofibroblastic tumor.

New research from Aaron Mansfield, an oncologist at Mayo Clinic, and George Vasmatzis, the co-director of the Biomarker Discovery Program of Mayo Clinic Center for Individualized Medicine, finds the drug ceritinib shows promise as a new treatment for inflammatory myofibroblastic tumors, a form of sarcoma.

Advertisement


The study also traced tumor growth to chromoplexy: a complex chromosomal rearrangement that causes genes to scramble, break DNA strands and then reassemble in a defective way. Dr. Mansfield's research, "Chromoplectic TPM3-ALK Rearrangement in a Patient With Inflammatory Myofibroblastic Tumor Who Responded to Ceritinib After Progression on Crizotinib," is published in the Annals of Oncology.

Investigators made the connection when a 32-year old man failed to respond to a nonsteroidal anti-inflammatory drug to shrink tumors in his lung, chest and buttock. Because there were no available clinical trials, researchers sought and gained U.S. Food and Drug Administration approval for compassionate use of ceritinib. Within two weeks, the patient started responding to the drug. After 18 months, he was well enough to undergo surgery to remove tumors from his lung and buttock.
Advertisement

Mayo researchers were able to conduct a new DNA test on the tumors known as mate pair sequencing. That test scans the entire genome, pinpointing genetic defects and chromosomal breaks. They found 142 genes had been impacted, many of which have known links to cancerous tumors.

"Mate pair sequencing helped identify these rearrangements, which may not have been seen with normal sequencing techniques," says Aaron Mansfield, the first author of the study. "We look forward to offering more patients this new, advanced type of DNA testing to discover potential causes and treatments for diseases."

Inflammatory myofibroblastic tumors often strike in children and young adults. The main form of treatment for patients with an inflammatory myofibroblastic tumor is surgery, but the tumors often reappear in different parts of the body. There is no standard of care for patients with inflammatory myofibroblastic tumors, thus making the discovery of tumor response to ceritinib all the more important.

Mayo Clinic investigators are recommending further study of this drug to determine whether it should be approved for individualized treatments.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Get Involved and Stand Up for Human Rights on Human Rights Day 2022
Coronary Artery Bypass Grafting
Macronutrients Calculator for Weight Loss
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Amyotrophic Lateral Sclerosis (ALS) Rhabdomyosarcoma 

Most Popular on Medindia

Blood - Sugar Chart Blood Pressure Calculator Diaphragmatic Hernia A-Z Drug Brands in India Iron Intake Calculator Vent Forte (Theophylline) Selfie Addiction Calculator Loram (2 mg) (Lorazepam) Noscaphene (Noscapine) Indian Medical Journals
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Understanding the Cause and Possible Treatment for a Rare Form of Sarcoma Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests